Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review

• Principais autores: Samira Samiee-Zafarghandy (Autor), Abdul Razak (Autor), Katelyn Sushko (Autor), Abdulrahman Salim Alsaadi (Autor), Vivian Bui (Autor)
• Formato: Livro
• Publicado em: BMJ Publishing Group, 2021-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background The use of vasoactive agents like arginine vasopressin (AVP) and terlipressin to treat hypotension or persistent pulmonary hypertension in critically ill preterm neonates is increasing. Therefore, a systematic review of the available data on dosing, efficacy and safety of AVP and terlipre...